Events

May
04
2021

The Psychedelic Therapeutics and Drug Development Conference

Science, Health & Medicine

Event Summary

The Psychedelic Therapeutics and Drug Development Conference is bringing together the world’s leading researchers in academia and industry to share novel research into psychedelic drug development.

Event Description

The Psychedelic Therapeutics and Drug Development Conference has been organized to bring together the world’s leading researchers and leaders in academia and industry to discuss the challenges and opportunities facing those engaged in the research and development of psychedelics for various health conditions with considerable unmet need. This event will highlight the progress being made towards regulatory approval of a variety of psychedelics with the potential to treat various conditions, including inflammatory/autoimmune disorders, brain injury, pain, PTSD, anxiety, ADHD, headaches, depression, and opioid use disorder.

Conference Themes:

Clinical trial design
Risk Evaluation & Mitigation Strategy (REMS)
Abuse potential
Practical use/indications/
DEA licensure & policy considerations
Targets for novel drug development
Dosage (micro/low/high)
Second generation psychedelic drug design
FDA regulatory guidance
Toxicology studies and considerations

Price

Industry - USD 450.0
Academic - USD 250.0
Non-Profit - USD 250.0
Government - USD 250.0
Student - USD 150.0

Links

BUY TICKETS NOW
BUY TICKETS NOW

The Psychedelic Therapeutics and Drug Development Conference is bringing together the world’s leading researchers in academia and industry to share novel research into psychedelic drug development.
Venue

United States
United States
US
67340

Contact

John Waslif
john.waslif@arrowheadpublishers.com
866-945-0263

Starts:
04-05-2021
14:30

Ends:
05-05-2021
20:00